Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phenylephrine Efficacy Will Be Questioned In Citizen Petition

This article was originally published in The Tan Sheet

Executive Summary

A pharmacy professor intends to file a citizen petition asking FDA to re-examine the effectiveness of the nasal decongestant phenylephrine after the agency refused a similar request by Congress
Advertisement

Related Content

Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
Wyeth Touts PE Efficacy Claims In Comments To FDA
Phenylephrine “Not Significantly Different From” Placebo – Schering Study
Waxman Renews Push For FDA Examination Of Phenylephrine Efficacy
Waxman Seeks Phenylephrine NDAC Review; Cites Efficacy Concerns
Oral Phenylephrine An “Ineffective” Replacement For PSE – Pharmacists
Oral Phenylephrine An “Ineffective” Replacement For PSE – Pharmacists
Pseudoephedrine Will Be Behind The Counter Across The Country By October

Topics

Advertisement
UsernamePublicRestriction

Register

PS099807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel